IL17A and fungal infectious disease: This may have led to an increase in IL-17A plasma levels even in study patients without a fungal infection, resulting in a relevant overlap between the different subgroups as well as leading to a relevant number of outliers in all subgroups of patients, especially in the early phase after sepsis onset.